Sabra Health Care REIT Inc. (NASDAQ:SBRA) finished Wednesday with an addition of $0.23 to close at $12.23, an upside of 1.92 percent. An average of 2,150,520 shares of common stock have been traded in the last five days. There was a gain of $0.23 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 2,095,825 shares traded, while the 50-day average volume stands at 2,133,036.
SBRA stock has decreased by -6.50% in the last month. The company shares reached their 1-month lowest point of $11.73 on 08/18/23. With the stock rallying to its 52-week high on 02/02/23, shares of the company touched a low of $10.08 and a high of $15.68 in 52 weeks. It has reached a new high 11 times so far this year and lost -1.61% or -$0.20 in price. In spite of this, the price is down -22.01% from the 52-week high.
Valuation Metrics
Sabra Health Care REIT Inc. (SBRA) stock’s beta is 1.30. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 4.43, the price-to-book (PB) ratio at 0.96, and the price-to-cash flow ratio at 13.69.
Financial Health
Further, the company has a long term debt to equity ratio of 0.82 and a total debt to equity ratio of 0.82 for the recent quarter. Its gross profit as reported stood at $140.66 million compared to revenue of $624.81 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Sabra Health Care REIT Inc.’s return on assets was -2.20%.
Earnings Surprise
For the recent quarter, Sabra Health Care REIT Inc. had $48.27 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $21.19 million in the quarter, while revenues of -$9.49 million were grew 20.67%. At the end of the recent quarter, Sabra Health Care REIT Inc.’s stock balance sheet showed total debt was $2.42 billion. Shareholders own equity worth $231.22 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Sabra Health Care REIT Inc. (SBRA) price momentum. RSI 9-day as of the close on 23 August was 44.86%, suggesting the stock is Neutral, with historical volatility in this time frame at 27.39%.
As of today, SBRA’s price is $12.00 +1.92% or $0.23 from its 5-day moving average. SBRA is currently trading -6.85% lower than its 20-day SMA and +8.23% higher than its 100-day SMA. However, the stock’s current price level is +4.00% above the SMA50 and -8.94% below the SMA200.
The stochastic %K and %D were 22.22% and 16.85%, respectively, and the average true range (ATR) was 0.26. With the 14-day stochastic at 32.68% and the average true range at 0.27, the RSI (14) stands at 45.46%. The stock has reached -0.12 on the 9-day MACD Oscillator while the 14-day reading was at -0.31.
Analyst Ratings
BofA Securities upgraded Sabra Health Care REIT Inc. (NASDAQ: SBRA) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as an Underperform. The consensus rating for Sabra Health Care REIT Inc. (SBRA) among analysts is Hold. According to current brokerage recommendations, 1 brokerage firm advise that investors sell SBRA, while 10 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
What is SBRA’s price target for the next 12 months?
Analysts predict a range of price targets between $11.00 and $15.00, with a median target of $13.00. Taking a look at these predictions, the average price target given by analysts for Sabra Health Care REIT Inc. (SBRA) stock is $13.21.
